CV Sciences Statistics
Total Valuation
CV Sciences has a market cap or net worth of $6.20 million. The enterprise value is $5.33 million.
| Market Cap | 6.20M |
| Enterprise Value | 5.33M |
Important Dates
The last earnings date was Monday, August 14, 2023, before market open.
| Earnings Date | Aug 14, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 163.23 million shares outstanding. The number of shares has increased by 6.29% in one year.
| Shares Outstanding | 163.23M |
| Shares Change (YoY) | +6.29% |
| Shares Change (QoQ) | +4.58% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.00% |
| Float | 163.20M |
Valuation Ratios
The trailing PE ratio is 1.83 and the forward PE ratio is 15.63.
| PE Ratio | 1.83 |
| Forward PE | 15.63 |
| PS Ratio | 0.39 |
| Forward PS | n/a |
| PB Ratio | 2.14 |
| P/FCF Ratio | 2.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.35, with an EV/FCF ratio of 2.36.
| EV / Earnings | 1.72 |
| EV / Sales | 0.33 |
| EV / EBITDA | 1.35 |
| EV / EBIT | 1.44 |
| EV / FCF | 2.36 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.30 |
| Quick Ratio | 0.29 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.20 |
| Interest Coverage | -412.33 |
Financial Efficiency
Return on equity (ROE) is 106.85% and return on invested capital (ROIC) is 109.15%.
| Return on Equity (ROE) | 106.85% |
| Return on Assets (ROA) | 11.77% |
| Return on Capital (ROIC) | 109.15% |
| Revenue Per Employee | $381,048 |
| Profits Per Employee | $73,857 |
| Employee Count | 42 |
| Asset Turnover | 1.33 |
| Inventory Turnover | 1.46 |
Taxes
In the past 12 months, CV Sciences has paid $50,000 in taxes.
| Income Tax | 50,000 |
| Effective Tax Rate | 1.59% |
Stock Price Statistics
The stock price has decreased by -15.78% in the last 52 weeks. The beta is 0.63, so CV Sciences's price volatility has been lower than the market average.
| Beta (1Y) | 0.63 |
| 52-Week Price Change | -15.78% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 54.81 |
| Average Volume (30 Days) | 244,077 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CV Sciences had revenue of $16.00 million and earned $3.10 million in profits. Earnings per share was $0.02.
| Revenue | 16.00M |
| Gross Profit | 7.09M |
| Operating Income | 3.71M |
| Pretax Income | 3.10M |
| Net Income | 3.10M |
| EBITDA | 3.95M |
| EBIT | 3.71M |
| Earnings Per Share (EPS) | $0.02 |
Balance Sheet
The company has $1.32 million in cash and $442,000 in debt, giving a net cash position of $875,000 or $0.01 per share.
| Cash & Cash Equivalents | 1.32M |
| Total Debt | 442,000 |
| Net Cash | 875,000 |
| Net Cash Per Share | $0.01 |
| Equity / Book Value | 2.90M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.82M |
Cash Flow
| Operating Cash Flow | 2.25M |
| Capital Expenditures | n/a |
| Free Cash Flow | 2.25M |
| FCF Per Share | $0.01 |
Margins
Gross margin is 44.27%, with operating and profit margins of 23.19% and 19.38%.
| Gross Margin | 44.27% |
| Operating Margin | 23.19% |
| Pretax Margin | 19.35% |
| Profit Margin | 19.38% |
| EBITDA Margin | 24.66% |
| EBIT Margin | 23.19% |
| FCF Margin | 14.08% |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.29% |
| Shareholder Yield | -6.29% |
| Earnings Yield | 50.01% |
| FCF Yield | 36.32% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CV Sciences has an Altman Z-Score of -3.18 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.18 |
| Piotroski F-Score | 7 |